Insider Sell: CFO Oluyemi Okupe Sells 9,912 Shares of Hims & Hers Health Inc (HIMS)
Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health Inc (NYSE:HIMS), has sold 9,912 shares of the company on March 20, 2024, according to a recent SEC filing. The transaction was executed at an average price of $15.82 per share, resulting in a total value of $156,755.84.
Hims & Hers Health Inc is a telehealth company that provides a modern approach to health and wellness. The company's platform connects consumers with licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Hims & Hers Health Inc aims to make healthcare more accessible and convenient through its telemedicine services and personalized treatment plans.
Over the past year, the insider has sold a total of 76,758 shares of Hims & Hers Health Inc and has not made any purchases of the stock. The recent sale by the insider is part of a series of transactions that have taken place over the last twelve months.
The insider transaction history for Hims & Hers Health Inc shows a pattern of insider selling, with 60 insider sells and no insider buys over the past year.
On the day of the insider's recent sale, shares of Hims & Hers Health Inc were trading at $15.82, giving the company a market capitalization of $3.584 billion.
The stock's price-to-GF-Value ratio stands at 1.25, indicating that Hims & Hers Health Inc is significantly overvalued according to the GF Value. The GF Value is a proprietary intrinsic value estimate from GuruFocus, which factors in historical trading multiples, a GuruFocus adjustment factor based on the company's past performance, and future business performance estimates from Morningstar analysts.
The GF Value for Hims & Hers Health Inc is currently set at $12.61, suggesting that the stock's market price is higher than its estimated intrinsic value.
Investors and analysts often monitor insider transactions as they can provide insights into a company's internal perspective on the stock's valuation and future prospects. The consistent pattern of insider selling at Hims & Hers Health Inc could be a point of consideration for current and potential shareholders.
For more detailed information on insider transactions and stock performance for Hims & Hers Health Inc (NYSE:HIMS), interested parties can refer to the full SEC filing.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
